Importantly, immunoblot from tumor tissues demonstrated that the suppression of ATF3/NOX4 axis in IFI6-overexpressed cells while this effect was reversed by phenformin treatment (Fig. 10h), validating the effect of IFI6-mediated OXPHOS efficiency on ATF3/NOX signaling pathway. The gene discussed is ATF3; the disease is neoplasm.